The pharmacokinetic and pharmacodynamic effects of SL65.1498, a GABA-A alpha2,3 selective agonist, in comparison with lorazepam in healthy volunteers.

Autor: de Haas SL, Franson KL, Schmitt JA, Cohen AF, Fau JB, Dubruc C, van Gerven JM
Zdroj: Journal of Psychopharmacology; Aug2009, Vol. 23 Issue 6, p625-632, 8p
Databáze: Complementary Index